LONDON, England, Jan. 29 (TNSjou) -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Jan 28, 2025: * * * - If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing - Submissions based on data from positive SWIFT and ANCHOR trials - SWIFT-1 and -2 showed depemokimab reduced exacerbation and hospitalisation rates as an add-on therapy for patients with asthma with type 2 inflammation - ANCHOR-1 and -2 showed dep  more

WASHINGTON, Jan. 28 -- The U.S. Department of Homeland Security's Immigration and Customs Enforcement issued the following news release: * * * ICE Boston arrests Honduran illegal alien charged with sex crimes, assault and battery, armed robbery BOSTON -- U.S. Immigration and Customs Enforcement Boston apprehended an illegally present, previously removed Honduran when officers with ICE Enforcement and Removal Operations Boston apprehended Juan Alberto Rodezno-Marin in Boston Jan. 22. Rodezno,   more

MIAMI, Florida, Jan. 28 (TNSres) -- The University of Miami Miller School of Medicine issued the following news: By Joey Garcia Patients living with HIV and in need of kidney transplants now have more donor options, as shown by the HIV Organ Policy Equity (HOPE) study. Published in the New England Journal of Medicine, the research, conducted in collaboration with the University of Miami Miller School of Medicine, demonstrates that kidney transplants from HIV-positive donors to HIV-positive re  more